Jump to content


  • Content count

  • Joined

  • Last visited

  • Days Won

  • Country

    United States

Patty last won the day on April 4

Patty had the most liked content!

About Patty

  • Rank
    Junior Member
  • Birthday 07/30/1954

Profile Information

  • Gender
  • Occupation
    Section Leader Transfusion Medicine

Recent Profile Visitors

283 profile views

    Here is the MAXQ Contact. He is very helpful with any questions you might have. Will Mitchell MaxQ Research LLC (c) 918.798.9606 | (e) willm@packmaxq.com (w) www.packmaxq.com

    If I validate the MAXQ cooler for 12 hours am I required to take/record a temp every 4 hours since it is considered Blood Storage? I doubt the cooler would ever be used for more than 4 hours but I suppose I should have something in place in case. How much validation would you suggest since it comes with a validation report?
  3. CAP TRM.30450

    It is my understanding that CAP requires Lot to Lot on Fetal screen Kits only, not commercial reagents since it is not a kit. You must compare the old QC with the new lot of reagents and the New QC with the old lot of reagents before use. Kit tests in the rest of the lab are handled the same way per CAP.
  4. CAP uniform antibody titer procedure

    Ortho On Demand has a three part series on Titrations that you might like. Ortho Clinical Diagnostics is pleased to present a Spotlight Series focusing on Standardization and Validation of Titrations in Perinatal Clinical Situations. https://presentations.akamaized.net/Shows/OrthoONDEMAND/Microsite/LoginPage.html
  5. Elution Studies

    We used to do eluates but with the infrequency of need and competency challenges we decided to send to our reference lab. We request eluates on patients who need a transfusion (or investigating a TRRX) and are DAT + and who have been transfused within the past 14 days to rule out newly forming antibodies that could be completely absorbed onto the donor RBCs and may not be found in the plasma. Our reference lab has recently changed from 14 to 21 days post transfusion for eluate testing but we have not yet changed our rule. I believe the thought process behind this is that after 14 (or 21) days the newly formed antibody has had sufficient time to spill over into the plasma and can be identified in the ABSC/ABID. On patients that are transfused frequently we sometimes opt to give phenotypically similar blood for transfusion instead of sending out for an eluate with each transfusion event as this is time consuming and expensive.
  6. CAP TRM. 40670

    All in fun!! I do appreciate the feedback as I need to address this at some point, like yesterday.
  7. CAP TRM. 40670

    Thank you for the clarification Malcolm. By the way this came right out of the current CAP standards. Maybe they need to be schooled too COMPUTER CROSSMATCHES A computer crossmatch is an electronic method that is used to confirm that the unit is appropriate for transfusion to the intended recipient through the use of validated software logic to determine compatibility, rather than serologic techniques. For laboratories that employ computer crossmatching, serologic crossmatch techniques must be employed when ABO typing discrepancies are present (e.g. mixed field reactivity, missing serum reactivity, apparent change in blood type post hematopoietic stem cell transplant).
  8. CAP TRM. 40670

    For laboratories that employ electronic crossmatching, serological crossmatch techniques must be employed when ABO typing discrepancies are present (e.g. mixed filed reactivity, missing serum reactivity, apparent change in blood type post hematopoietic stem cell transplant.) Does a discrepancy still exist if you have figured it out? (As in extra reverse reactions: rouleaux, cold autoagglutinins? Mixed field that you can explain: a B person who received O blood, an A sub group with Anti-A1 ; system set to transfuse type O blood) How are you satisfying this standard? By procedure only? With Immediate spin crossmatching? Is there any way in Cerner to block electroninic crossmatches for these instances? Thank you for your input.
  9. We currently check the BB Alarms by using iced water to bring the containers holding the probes to a temp down below 1.5 and warmer water to bring above 5.5. Our Helmer refrigerators have automatic alarm checks- press a button and POOF - done. Is the automatic check sufficient for all or part of the required checks? This is a question I ask myself every 3 months.

    Thank you for the information. I have a demo cooler on the way

    Do you have a catalog number or website for the MAXQ cooler you are referring to ? Is it a one time use? How did you get a demo to look at? Thanks for your help. We use the ARC boxes for occasional storage in ER and OR but would like to get something else.
  12. Thanks for the quick reply. Somehow I knew that would be to good to be true.
  13. I am not familiar with the Immucor AHG that does not detect IgG4. When using Immucor's AHG for testing patients after Dara treatment do you still see pan-agglutination? We are currently sending patients treated with Daratumumab to ARC reference lab for DDT treatment and transfusing K- blood if no antibodies are identified. After a molecular phenotype has been done we consider transfusing phenotypically similar blood without an antibody workup which requires a signed deviation form per patient. Both options are time consuming and expensive.
  14. Does anyone have a good method for determining if units packed to send with the patient/transport team are transfused to the patient, accepted into Inventory by the receiving hospital, or discarded?
  15. Did anyone listen to the Sept 20 CAP webinar that was mentioned below for standard changes? Was any clarification given? Do you know if it was recorded and can be accessed through the cap WEBSITE?